J. Safra Sarasin Holding AG Buys New Stake in Humana Inc. (NYSE:HUM)

J. Safra Sarasin Holding AG bought a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 5,967 shares of the insurance provider's stock, valued at approximately $1,514,000.

Other hedge funds also recently bought and sold shares of the company. Transcend Capital Advisors LLC boosted its stake in Humana by 399.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after purchasing an additional 2,914 shares during the period. FNY Investment Advisers LLC boosted its position in shares of Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after acquiring an additional 26,856 shares during the period. Retirement Systems of Alabama boosted its position in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. increased its position in Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after acquiring an additional 65,735 shares during the period. Finally, Secure Asset Management LLC acquired a new position in Humana during the 4th quarter valued at $244,000. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Up 5.3 %

Shares of NYSE HUM opened at $258.87 on Wednesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $31.24 billion, a price-to-earnings ratio of 26.02, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The firm's 50-day simple moving average is $265.74 and its 200 day simple moving average is $270.19.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.37%. Humana's payout ratio is 35.58%.

Wall Street Analyst Weigh In

Several analysts have issued reports on HUM shares. JPMorgan Chase & Co. decreased their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 18th. Piper Sandler boosted their price target on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. Mizuho raised their price objective on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Barclays boosted their price objective on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research report on Friday, April 11th. Finally, StockNews.com raised Humana from a "hold" rating to a "buy" rating in a research report on Monday, April 7th. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $284.90.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.